BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 15782140)

  • 1. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
    Edwards LA; Thiessen B; Dragowska WH; Daynard T; Bally MB; Dedhar S
    Oncogene; 2005 May; 24(22):3596-605. PubMed ID: 15782140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells.
    Persad S; Attwell S; Gray V; Delcommenne M; Troussard A; Sanghera J; Dedhar S
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3207-12. PubMed ID: 10716737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin-linked kinase (ILK) regulation of the cell viability in PTEN mutant glioblastoma and in vitro inhibition by the specific COX-2 inhibitor NS-398.
    Obara S; Nakata M; Takeshima H; Katagiri H; Asano T; Oka Y; Maruyama I; Kuratsu J
    Cancer Lett; 2004 May; 208(1):115-22. PubMed ID: 15105053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
    Haas-Kogan D; Shalev N; Wong M; Mills G; Yount G; Stokoe D
    Curr Biol; 1998 Oct; 8(21):1195-8. PubMed ID: 9799739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas.
    Nakamura JL; Karlsson A; Arvold ND; Gottschalk AR; Pieper RO; Stokoe D; Haas-Kogan DA
    J Neurooncol; 2005 Feb; 71(3):215-22. PubMed ID: 15735908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.
    Wick W; Furnari FB; Naumann U; Cavenee WK; Weller M
    Oncogene; 1999 Jul; 18(27):3936-43. PubMed ID: 10435616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin-linked kinase (ILK): a "hot" therapeutic target.
    Yoganathan TN; Costello P; Chen X; Jabali M; Yan J; Leung D; Zhang Z; Yee A; Dedhar S; Sanghera J
    Biochem Pharmacol; 2000 Oct; 60(8):1115-9. PubMed ID: 11007949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis.
    Davies MA; Lu Y; Sano T; Fang X; Tang P; LaPushin R; Koul D; Bookstein R; Stokoe D; Yung WK; Mills GB; Steck PA
    Cancer Res; 1998 Dec; 58(23):5285-90. PubMed ID: 9850049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells.
    Wang HQ; Altomare DA; Skele KL; Poulikakos PI; Kuhajda FP; Di Cristofano A; Testa JR
    Oncogene; 2005 May; 24(22):3574-82. PubMed ID: 15806173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells.
    Cruet-Hennequart S; Maubant S; Luis J; Gauduchon P; Staedel C; Dedhar S
    Oncogene; 2003 Mar; 22(11):1688-702. PubMed ID: 12642872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells.
    Taylor V; Wong M; Brandts C; Reilly L; Dean NM; Cowsert LM; Moodie S; Stokoe D
    Mol Cell Biol; 2000 Sep; 20(18):6860-71. PubMed ID: 10958682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK).
    Edwards LA; Woo J; Huxham LA; Verreault M; Dragowska WH; Chiu G; Rajput A; Kyle AH; Kalra J; Yapp D; Yan H; Minchinton AI; Huntsman D; Daynard T; Waterhouse DN; Thiessen B; Dedhar S; Bally MB
    Mol Cancer Ther; 2008 Jan; 7(1):59-70. PubMed ID: 18202010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo.
    Saito Y; Swanson X; Mhashilkar AM; Oida Y; Schrock R; Branch CD; Chada S; Zumstein L; Ramesh R
    Gene Ther; 2003 Nov; 10(23):1961-9. PubMed ID: 14528320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation.
    Troussard AA; Mawji NM; Ong C; Mui A; St -Arnaud R; Dedhar S
    J Biol Chem; 2003 Jun; 278(25):22374-8. PubMed ID: 12686550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
    Hu X; Pandolfi PP; Li Y; Koutcher JA; Rosenblum M; Holland EC
    Neoplasia; 2005 Apr; 7(4):356-68. PubMed ID: 15967113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
    Troussard AA; McDonald PC; Wederell ED; Mawji NM; Filipenko NR; Gelmon KA; Kucab JE; Dunn SE; Emerman JT; Bally MB; Dedhar S
    Cancer Res; 2006 Jan; 66(1):393-403. PubMed ID: 16397254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo.
    Choe G; Horvath S; Cloughesy TF; Crosby K; Seligson D; Palotie A; Inge L; Smith BL; Sawyers CL; Mischel PS
    Cancer Res; 2003 Jun; 63(11):2742-6. PubMed ID: 12782577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.